Morphotek Inc. Pilot Plant Receives 2013 Facility of the Year Award
2/4/2013 10:13:48 AM
More...
|
Morphotek Inc. farletuzumab Phase 3 Study Fails to Meet Primary Endpoint
1/11/2013 7:12:21 AM
More...
|
FDA Grants Orphan Drug Status to FDA's Amatuximab (MORAb-009)
11/12/2012 9:50:39 AM
More...
|
Morphotek Inc. Announces Initiation of MORAb-004 Phase II Study in Metastatic Soft Tissue Sarcoma
8/27/2012 9:50:37 AM
More...
|
Morphotek Inc. Opens 60,000-Square-Foot Manufacturing Plant
8/15/2012 10:41:36 AM
More...
|
Morphotek Inc. Opening Factory in Exton
8/14/2012 8:02:56 AM
More...
|
Morphotek Inc. Earns Prestigious Award For Innovation In Assay Development
5/30/2012 12:11:02 PM
More...
|
Morphotek Inc. Announces Initiation of MORAb-004 Phase 2 Study in Metastatic Colorectal Cancer
4/16/2012 10:26:52 AM
More...
|
Morphotek Inc. Announces Completion of Enrollment in the FAR-131 Trial for Relapsed Ovarian Cancer
3/28/2012 8:43:47 AM
More...
|
Morphotek Inc. Enters Into Agreements With Fox Chase Cancer Center to Acquire Clinical Samples for the Development and Validation of Companion Diagnostic Kits
1/11/2012 9:51:37 AM
More...
|
|